These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 3195486

  • 1. Disopyramide in hypertrophic cardiomyopathy. I. Hemodynamic assessment after intravenous administration.
    Pollick C, Kimball B, Henderson M, Wigle ED.
    Am J Cardiol; 1988 Dec 01; 62(17):1248-51. PubMed ID: 3195486
    [Abstract] [Full Text] [Related]

  • 2. Acute dose-response effects of intravenous disopyramide in hypertrophic obstructive cardiomyopathy.
    Kimball BP, Bui S, Wigle ED.
    Am Heart J; 1993 Jun 01; 125(6):1691-7. PubMed ID: 8498312
    [Abstract] [Full Text] [Related]

  • 3. Salutary effect of disopyramide on left ventricular diastolic function in hypertrophic obstructive cardiomyopathy.
    Matsubara H, Nakatani S, Nagata S, Ishikura F, Katagiri Y, Ohe T, Miyatake K.
    J Am Coll Cardiol; 1995 Sep 01; 26(3):768-75. PubMed ID: 7642872
    [Abstract] [Full Text] [Related]

  • 4. Effects of intravenous disopyramide on coronary hemodynamics and vasodilator reserve in hypertrophic obstructive cardiomyopathy.
    Hongo M, Nakatsuka T, Takenaka H, Tanaka M, Watanabe N, Yazaki Y, Sekiguchi M.
    Cardiology; 1996 Sep 01; 87(1):6-11. PubMed ID: 8631046
    [Abstract] [Full Text] [Related]

  • 5. Disopyramide in hypertrophic cardiomyopathy. II. Noninvasive assessment after oral administration.
    Pollick C.
    Am J Cardiol; 1988 Dec 01; 62(17):1252-5. PubMed ID: 3057852
    [Abstract] [Full Text] [Related]

  • 6. [Beneficial effects of disopyramide on left ventricular outflow obstruction in a case of hypertrophic obstructive cardiomyopathy].
    Terrosu P, Franceschino V, Contini GM, Dore L, Ibba GV.
    G Ital Cardiol; 1984 Jan 01; 14(1):63-6. PubMed ID: 6538527
    [Abstract] [Full Text] [Related]

  • 7. Effect of propranolol and disopyramide on left ventricular function at rest and during exercise in hypertrophic cardiomyopathy.
    Hartmann A, Kühn J, Hopf R, Klepzig H, Standke R, Kober G, Maul FD, Hör G, Kaltenbach M.
    Cardiology; 1992 Jan 01; 80(2):81-8. PubMed ID: 1611637
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects.
    Rosing DR, Kent KM, Borer JS, Seides SF, Maron BJ, Epstein SE.
    Circulation; 1979 Dec 01; 60(6):1201-7. PubMed ID: 574066
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Efficacy of continuous intravenous drip infusion of disopyramide in hypertrophic obstructive cardiomyopathy during cardiogenic shock: a case report].
    Kajimoto K, Harada T, Imamura K, Matsuda N, Niki K, Hagiwara N, Kasanuki H.
    J Cardiol; 2000 Mar 01; 35(3):197-203. PubMed ID: 10808427
    [Abstract] [Full Text] [Related]

  • 13. An equation to predict the changes in peak left ventricular pressure in hypertrophic obstructive cardiomyopathy after treatment: application to the administration of disopyramide.
    Niki K, Sugawara M, Tanino S, Iwade K, Hosoda S, Kasanuki H.
    Heart Vessels; 1999 Mar 01; 14(2):72-81. PubMed ID: 10651183
    [Abstract] [Full Text] [Related]

  • 14. Effect of disopyramide on systolic and early diastolic time intervals in patients with hypertrophic cardiomyopathy.
    Sumimoto T, Hamada M, Ohtani T, Shigematsu Y, Fujiwara Y, Sekiya M, Hiwada K.
    J Clin Pharmacol; 1991 May 01; 31(5):440-3. PubMed ID: 2050829
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hypertrophic obstructive cardiomyopathy. Effects of acute and chronic verapamil treatment on left ventricular systolic and diastolic function.
    Anderson DM, Raff GL, Ports TA, Brundage BH, Parmley WW, Chatterjee K.
    Br Heart J; 1984 May 01; 51(5):523-9. PubMed ID: 6539120
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.